Media playback is unsupported on your device

Pfizer boss: UK research commitment for AstraZeneca bid

13 May 2014 Last updated at 11:05 BST

The chief executive of Pfizer has pledged 20% of the company's research and development headcount to be based in the UK if the deal goes ahead for the proposed takeover of AstraZeneca.

While facing MPs about the merits of the takeover, Ian Read said it was a "unprecedented" commitment but he could not give details on potential expenditure.

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.